Article 293   Published on January 20, 2018

Psoriasis is a common dermatological or inflammatory skin disease and a lifelong autoimmune disease. About two to four percent of the adults were affected by psoriasis. An earlier study shows an association between psoriasis and the heart attack (the medical name is myocardial infarction), cardiovascular diseases, stroke, mortality (death), type 2 diabetes (T2D) and chronic inflammation.

A study at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, the United States shows the risk of type 2 diabetes (T2D) in the people with psoriasis and the risk of type 2 diabetes (T2D) increases with the severity of psoriasis. This is the first study exploring the effects on type 2 diabetes (T2D) with the severity of psoriasis. This study has found a biological connection between type 2 diabetes (T2D) and psoriasis. The study also found that psoriasis promotes insulin resistance.

A study on 8,124 people with psoriasis and 76,599 people without psoriasis, has collected the body surface area (BSA) of the psoriasis patients. The body surface area (BSA) shows the severity of psoriasis. They have done a follow-up study for four years.

The follow-up study shows a new type 2 diabetes development in 280 (3.44 percent) people in the psoriasis group and 1,867 (2.44 percent) people in without psoriasis group. Researchers accounted for risk factors to type 2 diabetes (T2D) such as the age of an individual, sex, obesity ( body mass index. BMI ). The study has found the following.

• About 21 percent of the increased risk of type 2 diabetes (T2D) in the people affected with psoriasis with a body surface area (BSA) up to two percent compared to people without psoriasis.

• About 64 percent of the higher risk of type 2 diabetes (T2D) in the patients affected with psoriasis with the body surface area (BSA) of ten percent or more compared to people without psoriasis.

• For every ten percent increase in the body surface area (BSA), the risk of type 2 diabetes (T2D) increases by 20 percent in psoriasis patients compared to people without psoriasis.

Researchers say that the healthcare professionals should provide a special attention for the prevention of type 2 diabetes (T2D) in the patients with psoriasis with the body surface area (BSA) more than ten, as they are at a higher risk to type 2 diabetes.

The lead author of the study was Joel M. Gelfand, a professor of dermatology and epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, the United States. The study was published November 8, 2017, in the Journal of the American Academy of Dermatology. Title of the article was "Psoriasis and the Risk of Diabetes: A Prospective Population-Based Cohort Study."
DOI : doi.org/10.1016/j.jaad.2017.10.050

       
If you like this article, please share it with a friend! Article address is (copy and paste the code below) :

Articles similar to this topic

1. Study show duration of psoriasis increases the risk of inflammation in blood vessels, cardiovascular diseases, heart attack and stroke
2. Risks With Psoriasis
3. Risk of type 2 diabetes, type 1.5 diabetes or latent autoimmune diabetes in adults (LADA) with high salt or sodium consumption
4. MonoPepT1De trial show slowdown in the development of type 1 diabetes with a retrained immune system
5. Inflammation hormones risk with glucose-gobbling immune cells hidden in the plaque of coronary artery disease CAD patients
6. BCG vaccine could restore proper immune response in type 1 diabetes
7. Autoimmune Diseases Decreases With Physical Exercise

8. Transplanting Bone Marrow To Cure Autoimmune Diseases
9. Risk Reduction To Inflammation Related Heart Diseases With Coffee Consumption
10. Raspberries could lower inflammation, high blood sugar or glucose levels and improves insulin sensitivity
11. A CT scan that can detect human coronary inflammation and helps us in gauging heart attack risk
12. Reduced heart inflammation by eating brightly colored lutein carotenoid vegetables
13. Lower risk of obesity and type 2 diabetes with the consumption of whole grains and milled whole grains
14. Ozempic (semaglutide) GLP-1 type 2 diabetes drugs from Novo Nordisk can reduce obesity and body fat levels

Sitemaps

Sitemap 1   Sitemap 2   Sitemap 3   Sitemap 4

The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.

Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.